Lung Cancer

SBRT on oligoprogressive lesions: Benefit in lung cancer

November 8, 2021

Severe COVID two times higher for cancer patients

November 8, 2021

Antibiotic and glucocorticoid use before cancer therapy could have detrimental effect on outcomes

October 28, 2021

Lung cancer screening rates in U.S. nowhere near goal

October 28, 2021

Pfizer offers refund if drug ‘doesn’t work’

October 20, 2021

Lung Cancer

Could your patient benefit? New trials in lung cancer

October 18, 2021

Lung Cancer

Many patients, doctors unaware of advancements in cancer care

October 4, 2021

Study supports chemotherapy with immunotherapy for some never-smokers with lung cancer

September 28, 2021

Should Geriatric Veterans Get Immunotherapy?

September 24, 2021

Most community-based oncologists skip biomarker testing

September 21, 2021

FDA approves first oral drug for NSCLC with EGFR Exon 20 insertion

September 20, 2021

Immunotherapy for cancer patients with poor PS needs a rethink

September 20, 2021

COVID is especially dangerous for mesothelioma

September 15, 2021

Lung Cancer

Pandemic strategies to boost trial enrollment should stay

September 13, 2021

Air pollution – second leading cause of lung cancer

September 13, 2021